Brain Mechanisms of Reducing Polysubstance Use

Multiple Drug Use Clinical Trial

Official title:
Brain Mechanisms of Reducing Polysubstance Use Following a Novel Body-mind Intervention 2

Status Recruiting

Clinical Trial Summary

The proposed study will test whether neurofeedback (NF) could optimize integrative body-mind training (IBMT) practice.

Clinical Trial Description

The proposed study will test whether real-time NF could optimize IBMT practice and improve effects in reducing polysubstance use through targeting self-control networks in the brain. ;

Study Design

Related Conditions & MeSH terms

Multiple Drug Use

Clinical Trial Details

NCT number	NCT06324786
Study type	Interventional
Source	Arizona State University
Contact	YiYuan Tang
Phone	4807903577
Email	yiyuan@asu.edu
Status	Recruiting
Phase	N/A
Start date	September 1, 2023
Completion date	August 31, 2026

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT06214130` - Bioavailability of Orfiril Long 500 mg Prolonged-Release Minitablets and Ergenyl Chrono 500 mg Prolonged-Release Tablets	Phase 1
Completed	`NCT01689493` - Strategy to Improve Antiplatelet Therapy Adherence After Coronary Stent Implantation	N/A
Recruiting	`NCT01758679` - A Clinical Trail of Iodine[131I] Metuximab Injection With CIK Cells for Preventing Hepatocellular Carcinoma	Phase 4
Completed	`NCT04261504` - Brain Mechanisms of Reducing Polysubstance Use Following a Novel Body-mind Intervention	N/A